Shares of Amdocs Limited (NASDAQ:DOX) have received an average rating of “Hold” from the nine research firms that are covering the company, MarketBeat reports. Five analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $69.03.
Several research firms have recently weighed in on DOX. BidaskClub raised shares of Amdocs from a “sell” rating to a “hold” rating in a report on Wednesday, March 21st. Stifel Nicolaus boosted their price objective on shares of Amdocs from $72.00 to $75.00 and gave the company a “buy” rating in a report on Wednesday, January 31st. Oppenheimer reissued a “buy” rating and set a $77.00 price objective on shares of Amdocs in a report on Wednesday, January 31st. Jefferies Group raised shares of Amdocs from a “hold” rating to a “buy” rating and reduced their target price for the company from $71.37 to $60.20 in a report on Monday, March 19th. Finally, Zacks Investment Research raised shares of Amdocs from a “sell” rating to a “hold” rating in a report on Tuesday, January 16th.
Shares of NASDAQ:DOX traded up $0.53 during mid-day trading on Friday, hitting $66.72. 493,352 shares of the company traded hands, compared to its average volume of 700,728. Amdocs has a 1 year low of $60.30 and a 1 year high of $71.72. The stock has a market capitalization of $9,569.18, a price-to-earnings ratio of 18.79, a PEG ratio of 2.26 and a beta of 0.55.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 20th. Shareholders of record on Friday, March 30th will be issued a dividend of $0.25 per share. This is a boost from Amdocs’s previous quarterly dividend of $0.22. This represents a $1.00 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date of this dividend is Wednesday, March 28th. Amdocs’s dividend payout ratio is currently 28.17%.
Hedge funds have recently made changes to their positions in the business. Delpha Capital Management LLC purchased a new stake in Amdocs during the fourth quarter valued at approximately $109,000. Focused Wealth Management Inc bought a new position in shares of Amdocs in the fourth quarter worth approximately $157,000. American International Group Inc. bought a new position in shares of Amdocs in the fourth quarter worth approximately $199,000. CENTRAL TRUST Co boosted its position in shares of Amdocs by 45.0% in the fourth quarter. CENTRAL TRUST Co now owns 3,388 shares of the technology company’s stock worth $222,000 after purchasing an additional 1,052 shares during the period. Finally, Cerebellum GP LLC bought a new position in shares of Amdocs in the fourth quarter worth approximately $246,000. 93.46% of the stock is owned by institutional investors and hedge funds.
Amdocs Company Profile
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.